MedPath

AlkaliDx, Inc.

Ownership
Private
Employees
-
Market Cap
-
Website

Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective

Phase 1
Conditions
ADHD
Interventions
Drug: Placebo oral capsule
First Posted Date
2018-06-20
Last Posted Date
2018-06-20
Lead Sponsor
AlkaliDx, Inc.
Target Recruit Count
100
Registration Number
NCT03563573
Locations
🇺🇸

Clinical Research Center of New Jersey (CRCNJ), Voorhees, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath